Pink Sheet is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Supplement GMPs

This article was originally published in The Tan Sheet

Executive Summary

Proposed rule has been "kicked back" to FDA for revision, NNFA Exec VP David Seckman tells Natural Products Expo East Capitol Hill briefing Oct. 11. "There have been some questions asked" by the Office of Management & Budget "and that's actually a good sign," Seckman maintains. The proposed reg was sent to OMB on March 28. One topic OMB may have asked FDA to re-examine is how the reg handles intentional tampering of supplements in light of ongoing terrorist concerns
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS093150

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel